Outcomes of African American kidney transplant recipients treated with sirolimus, tacrolimus, and corticosteroids

Transplantation

Volumn 74, Issue 2, 2002, Pages 189-193

  Hricik, Donald E ^a,c   Anton, Hany A S ^a   Knauss, Thomas C ^a   Rodriguez, Victoria ^a   Seaman, David ^b   Siegel, Christopher ^b   Valente, John ^b   Schulak, James A ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; COTRIMOXAZOLE; DAPSONE; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTAMIDINE; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; NEGRO; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RECIPIENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0037183179     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200207270-00008     Document Type: Article

References (25)

1. Impact of race on the outcome of renal transplantation under cyclosporine-prednisone
2. Kidney graft survival rates in black cyclosporine-treated recipients
3. Improved survival of primary cadaveric renal allografts in blacks with quadruple immonosuppression
4. Multifactorial analysis of renal transplants reported to the United Network for Organ Sharing Registry: A 1994 update
5. Racial differences in renal allograft survival: The role of systemic hypertension
6. Racial differences in the survival of cadaveric renal allografts: Overriding effects of HLA matching and socioeconomic factors
7. HLA-A, -B, -DR, -DQ antigens in black North Americans
8. The effect of Lewis antigen and race on kidney survival
9. Renal allograft survival in African Americans: Influence of duffy blood group
10. Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients
11. Decreased effect of immunosuppression on immunocompetence in African-Americans after kidney and liver transplantation
12. What causes center effects in kidney transplantation?
13. Important risk factors of allograft survival in cadaveric renal transplantation: A study of 426 patients
14. Cyclosporlne bioavailability: Dosing implications and impact on clinical outcomes in select transplantation subpopulations
15. Immunosuppressive therapy in high-risk transplant patients
16. Racial difference in renal transplantation after immunosuppression with tacrolimus versus cyclosporine
17. Sirolimus-tacrolimus combination immunosuppression
18. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immonosuppressive regimen
19. Does race affect renal transplant results? A single institution study
20. Effect of mycophenolate mofetil on long-term outcomes in African American renal transplant recipients
21. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: A randomized multicenter study
22. Sirolimus improves the two-year outcome of renal allografts in African American patients
23. Diabetes mellitus after renal transplantation in the cyclosporine era: An analysis of risk factors
24. Median effect analysis of efficacy versus adverse effects of immunosuppressants
25. Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in rat brain